AMY ALSTON: Open Payments
NPI 1013528629 · METAIRIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,389 in 87 payments from 24 companies in 2025. Trend: 2023 $373 · 2024 $786 · 2025 $2,389
Food & beverage: $2,175Education: $215
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 17 | $499 |
| Janssen Biotech, Inc. | 7 | $227 |
| Incyte Corporation | 7 | $222 |
| Organon LLC | 5 | $205 |
| LEO Pharma Inc. | 11 | $182 |
| Galderma Laboratories, L.P. | 3 | $167 |
| Regeneron Healthcare Solutions, Inc. | 8 | $154 |
| E.R. Squibb & Sons, L.L.C. | 4 | $103 |
| SANOFI-AVENTIS U.S. LLC | 1 | $95 |
| UCB, Inc. | 3 | $92 |
Products named: DUPIXENT, TREMFYA, OPZELURA, VTAMA, NEMLUVIO, ADBRY, Bimzelx, Sotyktu.
Industry payments across LA — which companies pay providers there.
